Long-term safety of Infliximab for the treatment of inflammatory bowel disease: Does blocking TNFα reduce colitis-associated colorectal carcinogenesis?

Onali S.;
2009-01-01
2009
Inglese
GUT
58
12
1703
1703
1
WOS:000271911900025
2-s2.0-72549112691
19923350
Comitato scientifico
internazionale
scientifica
antibodies monoclonal; cell transformation neoplastic; colorectal neoplasms; gastrointestinal agents; humans; inflammatory bowel diseases; infliximab; tumor necrosis factor-alpha
no
Biancone, L.; Petruzziello, C.; Calabrese, E.; Zorzi, F.; Naccarato, P.; Onali, S.; Pallone, F.
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
7
reserved
Files in This Item:
File Size Format  
Gut-2009-Biancone-1703.pdf

Solo gestori archivio

Size 95.81 kB
Format Adobe PDF
& nbsp; View / Open   Request a copy
95.81 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie